Ameritas Advisory Services’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Ameritas Advisory Services's GILD Position: Q2 2026 in Review
Ameritas Advisory Services reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $124K and leaving 7,390 shares worth $934K. The position accounts for 0.02% of the portfolio, ranked #578.
Ameritas Advisory Services first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.81M in Q4 2025. 2,284 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Ameritas Advisory Services held 7,390 shares of Gilead Sciences worth $934K as of Q2 2026.
- Ameritas Advisory Services sold 938 Gilead Sciences shares in Q2 2026, an estimated $124K.
- Gilead Sciences made up 0.02% of Ameritas Advisory Services's portfolio in Q2 2026, its #578 holding.
- Ameritas Advisory Services first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- Ameritas Advisory Services's Gilead Sciences position peaked at $1.81M in Q4 2025.
- 2,284 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.